• Doxycycline: Research Context and Evidence

  2026-10-05

  Doxycycline is a tetracycline antibiotic used in antimicrobial, host-response, metalloproteinase, gene-regulation, and cancer research. This overview separates established pharmacology from exploratory applications, compares evidence across cellular, animal, and clinical settings, and explains why antiproliferative findings should not be interpreted as proof of anticancer efficacy. It also distinguishes doxycycline from doxorubicin, the drug examined in the supplied nanocarrier study, and outlines important limitations involving exposure, tissue distribution, mitochondrial effects, microbiome changes, and model relevance.

• Cell Integrity and Ploidy Limits in Budding Yeast

  2026-10-05

  Barker, Murray, and Bell show that budding yeast can reach approximately 32–64C DNA content through repeated genome duplication, but that ploidy is constrained by cell-surface integrity rather than by chromosome content alone. The study connects increasing cell size and surface stress with an upper limit to polyploidy and identifies repression of ergosterol-biosynthesis genes as a molecular correlate, while leaving direct translational and antifungal implications open.

• Cy3 NHS Ester (Non-Sulfonated): Product Overview

  2026-10-04

  Cy3 NHS ester (non-sulfonated), SKU A8100, is a supplier-described orange fluorescent dye for conceptual amino-group labeling of proteins, peptides, and oligonucleotides. No matched paper evidence was provided, so performance claims remain unverified.

• Bile Acid Retention and Immune Escape in MASH-HCC

  2026-10-03

  A 2026 Cancer Letters study identifies a GPR120–FXR/ABCB11–bile acid–NLRC5 pathway that connects lipid-associated metabolic stress with defective MHC-I antigen presentation in MASH-HCC. Its genetic and pharmacological evidence suggests that reducing intracellular bile acid retention can improve tumor antigenicity and strengthen anti-PD-1 responses in mouse models, while clinical applicability remains un established.

• MOG (35-55) in EAE Research Workflows

  2026-10-02

  MOG (35-55) provides a sequence-defined trigger for experimental autoimmune encephalomyelitis, supporting controlled studies of neuroinflammation, demyelination, and immune-modulatory therapies. Its value increases when peptide handling, strain selection, and pathway-level assays are integrated into one reproducible workflow.

• PARP7 Inhibition Stabilizes STAT1/2 in EAE

  2026-10-01

  Xu et al. identify PARP7 as a suppressor of type I interferon signaling that ADP-ribosylates STAT1 and STAT2, promoting their ubiquitination and p62-dependent autophagic degradation. Inhibition of PARP7 restored interferon pathway activity and reduced experimental autoimmune encephalomyelitis in mice, linking a defined post-translational mechanism to disease-relevant neuroinflammation.

• Bifurcated Redox Sensing by TRPV1 and TRPA1

  2026-10-01

  The reference study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide rather than responding to reactive oxygen species uniformly. By combining electrophysiology, calcium imaging, agonist-selective testing, and residue analysis, it identifies divergent channel responses with implications for mechanistic redox signaling studies.

• Bifurcated ROS Sensing by TRPV1 and TRPA1

  2026-09-30

  The reference study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide through different channel-specific mechanisms. Its combination of electrophysiology, calcium imaging, agonist-selective testing, and residue analysis provides a framework for interpreting reactive oxygen species effects on ion-channel signaling.

• MK-8745: Selective Aurora A Inhibitor Workflows

  2026-09-30

  MK-8745 enables controlled studies of Aurora A–dependent mitotic arrest, tetraploidy, and apoptosis across cancer cell models. This workflow connects biochemical potency with practical experiments in p53 biology, non-Hodgkin lymphoma, retinoblastoma research, and tumor xenograft models while emphasizing formulation and interpretation controls.

• Rosiglitazone Workflow for PPARγ Metabolic Studies

  2026-09-29

  Build reproducible adipogenesis, insulin-response, and PPARG-variant rescue assays with Rosiglitazone, also known as Brl-49653. This guide connects practical dosing and controls with a recent FPLD3 study that used receptor activation to probe protein instability, mitochondrial dysfunction, and metabolic rescue.

• Carvacrol in Redox-Resolved Cell Assays

  2026-09-29

  Carvacrol is more than a TRPA1 agonist: it can help researchers separate reactive oxygen species sensing from downstream cell-fate responses. This guide translates recent channel biology into rigorous assay design for cell cycle research, apoptosis research, and mechanistic validation.

• KN-62: From CaMKII Mechanism to Translation

  2026-09-28

  KN-62 provides a focused pharmacological route to interrogate CaMKII-linked calcium signaling, secretion, metabolism, and cell-cycle phenotypes. This article connects that tool to emerging evidence that proteolytic signaling sustains social memory, while defining the controls translational researchers need before extending findings across biological domains.

• MOG (35-55): EAE Workflow and Assay Insights

  2026-09-28

  Use MOG (35-55) to establish a defined antigen challenge for experimental autoimmune encephalomyelitis (EAE) and investigate neuroinflammation in a multiple sclerosis research setting. This guide connects peptide handling and study design with recent evidence that PARP7 inhibition can alter type I interferon signaling and EAE outcomes.

• miR-18a–ALOXE3 Signaling in Glioblastoma

  2026-09-27

  The study identifies a tumor-suppressive role for ALOXE3 in glioblastoma: its loss reduces ferroptotic sensitivity and promotes migration through lipid signaling. It places miR-18a upstream of ALOXE3, outlining a molecular axis that connects microRNA regulation, cell death, and tumor behavior while leaving important questions about clinical translation unresolved.

• Autophagy, Lipid Breakdown, and Salmon Lipotoxicity

  2026-09-26

  In Atlantic salmon SHK-1 cells, rapamycin-induced autophagy was associated with lipid-droplet breakdown and reduced lipotoxic stress, while lipidomics and proteomics revealed changes in lipid storage and lipogenic proteins. The study provides a fish-cell model for investigating lipophagy and highlights why lipid composition and autophagic activity should be assessed together rather than treating total lipid abundance as the sole outcome.

8368 records 1/558 page Next 12345 下5页 Last page